Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 4/20 | 0.59 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.53 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.53 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.51 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.51 |
| ▸ | METTL14 | Q9HCE5 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1689441 | 0.90 | METTL3 (0.52) | ADKPRMT5WDR77SLC29A1METTL3 | |
| SCHEMBL1689438 | 0.90 | METTL3 (0.52) | ADKPRMT5WDR77SLC29A1METTL3 | |
| SCHEMBL10160817 | 0.89 | ADK (0.64) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL1797344 | 0.89 | ADK (0.64) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL10131093 | 0.89 | ADK (0.64) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL13005628 | 0.89 | ADK (0.64) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL14440901 | 0.88 | ADK (0.63) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL14440630 | 0.88 | ADK (0.63) | ADKSLC29A1METTL3METTL14 | |
| SCHEMBL19696624 | 0.83 | ADK (0.54) | ADKPRMT5WDR77METTL3METTL14 | |
| SCHEMBL23544706 | 0.81 | ADK (0.53) | ADKMETTL3METTL14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | disclosed |